Seven Years of Biosimilar Experience in the U.S., Where Untapped Value Remains
By: Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Biosimilars Implementation in the United States: Where Opportunities Remain
By: Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
